These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38944486)

  • 1. Pediatric Immune Thrombocytopenia.
    Gotesman M; Shear M; Raheel S; Procassini M; Panosyan EH
    Adv Pediatr; 2024 Aug; 71(1):229-240. PubMed ID: 38944486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group.
    Neunert C; Heitink-Polle KMJ; Lambert MP
    Br J Haematol; 2023 Oct; 203(1):17-22. PubMed ID: 37641973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT; Gonzalez CE; Sandler SG
    Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical prediction score for transient versus persistent childhood immune thrombocytopenia.
    Schmidt DE; Wendtland Edslev P; Heitink-Pollé KMJ; Mertens B; Bruin MCA; Kapur R; Vidarsson G; van der Schoot CE; Porcelijn L; van der Bom JG; Rosthøj S; de Haas M
    J Thromb Haemost; 2021 Jan; 19(1):121-130. PubMed ID: 33058474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
    J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia.
    Morimoto Y; Yoshida N; Kawashima N; Matsumoto K; Kato K
    Int J Hematol; 2014; 99(5):597-602. PubMed ID: 24573984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
    Blanchette V; Carcao M
    Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood acute immune thrombocytopenic purpura: 20 years later.
    Blanchette VS; Carcao M
    Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.
    Güngör T; Arman Bilir Ö; Koşan Çulha V; Güngör A; Kara A; Azık FM; Yaralı HN
    Pediatr Neonatol; 2019 Aug; 60(4):411-416. PubMed ID: 30470618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
    Pugina SA; Evdokimova NM; Rastorguev GG; Samoĭlova OS; Sorokina IV; Sidnev GV; Vasil'ev DM; Anastasiev VV; Milovidova OV; Molodovskaia EV; Borovkov NN
    Ter Arkh; 1999; 71(8):50-4. PubMed ID: 10515038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune thrombocytopenia purpura.
    Hunt CW
    Medsurg Nurs; 2010; 19(4):237-9. PubMed ID: 20860250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological stratification of clinical disease courses in childhood immune thrombocytopenia.
    Schmidt DE; Heitink-Pollé KMJ; Mertens B; Porcelijn L; Kapur R; van der Schoot CE; Vidarsson G; van der Bom JG; Bruin MCA; de Haas M
    J Thromb Haemost; 2021 Apr; 19(4):1071-1081. PubMed ID: 33386662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
    Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T
    Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulins ameliorate thrombin-related platelet functions in childhood immune thrombocytopenia.
    Kapur R
    Br J Haematol; 2023 Jun; 201(6):1019-1020. PubMed ID: 36924289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune thrombocytopenia.
    Maher GM
    S D Med; 2014 Oct; 67(10):415-7. PubMed ID: 25423768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue Fever: A Rare Cause Of Immune Thrombocytopenia.
    Ramírez-Fonseca T; Segarra-Torres A; Jaume-Anselmi F; Ramírez-Rivera J
    Bol Asoc Med P R; 2015; 107(2):51-3. PubMed ID: 26434084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic thrombocytopenic purpura (ITP): immunomodulation by intravenous immunoglobulin (IVIg).
    Imbach P; Morell A
    Int Rev Immunol; 1989; 5(2):181-8. PubMed ID: 8691051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients.
    Spahr JE; Rodgers GM
    Am J Hematol; 2008 Feb; 83(2):122-5. PubMed ID: 17874448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.